CBiPES
(preusmereno sa LY-566,332)
 | |
| Klinički podaci | |
|---|---|
| Drugs.com | Monografija |
| Identifikatori | |
| CAS broj | 856702-40-4  |
| ATC kod | none |
| PubChem | CID 9864510 |
| ChemSpider | 8040202 |
| Hemijski podaci | |
| Formula | C21H19N3O2S |
| Molarna masa | 377,459 |
| |
| |
CBiPES je lek koji se koristi u naučnim istraživanjima koji deluje kao selektivni pozitivni alosterični modulator za metabotropni glutamat receptor grupe II podtip mGluR2. On ima potencijalno antipsihotične efekte na životinjskim modelima i koristi se za istraživanje uloge mGluR2 receptora u šizofreniji i srodnim poremećajima.[1][2][3]
Osobine
[uredi | uredi izvor]CBiPES je organsko jedinjenje, koje sadrži 21 atom ugljenika i ima molekulsku masu od 377,459 Da.
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 4 |
| Broj donora vodonika | 0 |
| Broj rotacionih veza | 6 |
| Particioni koeficijent[4] (ALogP) | 3,1 |
| Rastvorljivost[5] (logS, log(mol/L)) | -6,0 |
| Polarna površina[6] (PSA, Å2) | 82,4 |
Reference
[uredi | uredi izvor]- ^ Johnson MP, Barda D, Britton TC, Emkey R, Hornback WJ, Jagdmann GE, et al. (април 2005). „Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)”. Psychopharmacology. 179 (1): 271—83. PMID 15717213. S2CID 2699540. doi:10.1007/s00213-004-2099-9.
- ^ Fell MJ, Katner JS, Johnson BG, Khilevich A, Schkeryantz JM, Perry KW, Svensson KA (март 2010). „Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge”. Neuropharmacology. 58 (3): 632—9. PMID 19951716. S2CID 7262560. doi:10.1016/j.neuropharm.2009.11.014.
- ^ Sanger H, Hanna L, Colvin EM, Grubisha O, Ursu D, Heinz BA, et al. (март 2013). „Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR”. Neuropharmacology. 66: 264—73. PMID 22659090. S2CID 42448364. doi:10.1016/j.neuropharm.2012.05.023.
- ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
- ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[uredi | uredi izvor]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
